Towards an understanding of the adjuvant action of aluminium

Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

Mosmann, T. R., Cherwinski, H. M., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,553

Gout-associated uric acid crystals activate the NALP3 inflammasome

Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326

Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization

Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065

Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica

Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658 · cited 1×

How dying cells alert the immune system to danger

Kono, H., & Rock, K. L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2215 · Cited by 1,737

Molecular identification of a danger signal that alerts the immune system to dying cells

Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684

Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants

Eisenbarth, S. C., Colegio, O. R., O’Connor, W., Sutterwala, F. S., & Flavell, R. A. (2008) · Nature · doi:10.1038/nature06939 · Cited by 1,542

Toll-like receptors control activation of adaptive immune responses

Schnare, M., Barton, G. M., Czopik, A. K., Takeda, K., Akira, S., & Medzhitov, R. M. (2001) · Nature Immunology · doi:10.1038/ni712 · Cited by 1,364

Disruption of the murine IL-4 gene blocks Th2 cytokine responses

Köpf, M., Gros, G. S. L., Bachmann, M. F., Lamers, M. C., Bluethmann, H., & Köhler, G. (1993) · Nature · doi:10.1038/362245a0 · Cited by 1,202

Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells

Kool, M., Soullié, T., van Nimwegen, M., Willart, M. A. M., Muskens, F., Jung, S., Hoogsteden, H. C., Hammad, H., & Lambrecht, B. N. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071087 · Cited by 1,014

Overcoming scientific barriers in the transition from in vivo to non-animal batch testing of human and veterinary vaccines

van den Biggelaar, R. H. G. A., Hoefnagel, M. H. N., Vandebriel, R. J., Sloots, A., Hendriksen, C. F. M., van Eden, W., Rutten, V. P. M. G., & Jansen, C. A. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1977628 · Cited by 20

Self‐Assembly of Immune Signals to Program Innate Immunity through Rational Adjuvant Design

Bookstaver, M. L., Zeng, Q., Oakes, R. S., Kapnick, S. M., Saxena, V., Edwards, C., Venkataraman, N., Black, S. K., Zeng, X., Froimchuk, E., et al. (2022) · Advanced Science · doi:10.1002/advs.202202393 · Cited by 19

A C-type lectin induces NLRP3 inflammasome activation via TLR4 interaction in human peripheral blood mononuclear cells

Ikenohuchi, Y. J., Silva, M. D. S., Rego, C. M. A., Francisco, A. F., da Silva Setúbal, S., Ferreira e Ferreira, A. A., Boeno, C. N., Santana, H. M., Felipin, K. P., de Lima, A. M., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04839-z · Cited by 20

Simultaneous enhancement of cellular and humoral immunity by the high salt formulation of Al(OH)3 adjuvant

Luo, M., Shao, B., Yu, J., Liu, T., Liang, X., Lu, L., Ye, T., He, Z., Xiao, H., & Wei, X. (2017) · Cell Research · doi:10.1038/cr.2017.14 · Cited by 20

A supramolecular hydrogel to boost the production of antibodies for phosphorylated proteins

Wang, Y., Li, X., Zhang, Y., Wang, L., & Yang, Z. (2019) · Chemical Communications · doi:10.1039/c9cc05633e · Cited by 20

Innate Immune Response against Hepatitis C Virus: Targets for Vaccine Adjuvants

Sepúlveda‐Crespo, D., Resino, S., & Martínez, I. (2020) · Vaccines · doi:10.3390/vaccines8020313 · Cited by 20

Uric acid and the vaccine adjuvant activity of aluminium (oxy)hydroxide nanoparticles

Thakkar, S. G., Xu, H., Li, X., & Cui, Z. (2018) · Journal of drug targeting · doi:10.1080/1061186x.2018.1428808 · Cited by 20

The stimulatory effect of the TLR4-mediated adjuvant glucopyranosyl lipid A is well preserved in old age

Weinberger, B., Joos, C., Reed, S. G., Coler, R., & Grubeck-Loebenstein, B. (2016) · Biogerontology · doi:10.1007/s10522-015-9576-x · Cited by 19

Serum Cytokine Profiles Associated with Specific Adjuvants Used in a DNA Prime-Protein Boost Vaccination Strategy

Buglione‐Corbett, R., Pouliot, K., Marty-Roix, R., West, K., Wang, S., Lien, E., & Lu, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074820 · Cited by 19

Plant Viruses as Adjuvants for Next-Generation Vaccines and Immunotherapy

Nikitin, N. A., Vasiliev, Y. M., Kovalenko, A. O., Ryabchevskaya, E. M., Kondakova, O. A., Evtushenko, E. A., & Karpova, O. V. (2023) · Vaccines · doi:10.3390/vaccines11081372 · Cited by 19

The novel complex combination of alum, CpG ODN and HH2 as adjuvant in cancer vaccine effectively suppresses tumor growth in vivo

Tian, Y., Li, M., Yu, C., Zhang, R., Zhang, X., Huang, R., Lu, L., Yuan, F., Fan, Y., Zhou, B., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17504 · Cited by 19

Nasal vaccination with poly(β-amino ester)-poly( d , l -lactide- co -glycolide) hybrid nanoparticles

Sinani, G., Sessevmez, M., Gök, M. K., Özgümüş, S., Okyar, A., Alpar, H. O., & Cevher, E. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.06.053 · Cited by 19

Aluminium adjuvants used in vaccines

Djurisic, S., Jakobsen, J. C., Petersen, S. B., Kenfelt, M., Klingenberg, S. L., & Gluud, C. N. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013086 · Cited by 22

Self-assembling synthetic nanoadjuvant scaffolds cross-link B cell receptors and represent new platform technology for therapeutic antibody production

Senapati, S., Darling, R. J., Ross, K. A., Wannemuehler, M. J., Narasimhan, B., & Mallapragada, S. K. (2021) · Science Advances · doi:10.1126/sciadv.abj1691 · Cited by 19

In situ real time monitoring of emulsification and homogenization processes for vaccine adjuvants

Ralbovsky, N. M., Soukup, R. J., Lomont, J. P., Lauro, M. L., Gulasarian, A., Saha-Shah, A., Winters, M. A., Richardson, D. D., Wang, S.-C., Mangion, I. K., et al. (2021) · The Analyst · doi:10.1039/d1an01797g · Cited by 19

The avian influenza vaccine Emerflu. Why did it fail?

Young, B. E., Sadarangani, S. P., & Leo, Y. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.1059760 · Cited by 19

Improving the efficacy of a prophylactic vaccine formulation against lymphatic filariasis

Chauhan, N., Banerjee, P., Khatri, V., Canciamille, A., Gilles, J. A., & Kalyanasundaram, R. (2017) · Parasitology Research · doi:10.1007/s00436-017-5593-9 · Cited by 19

Pristine mesoporous carbon hollow spheres as safe adjuvants induce excellent Th2-biased immune response

Jambhrunkar, M., Yu, M., Zhang, H., Abbaraju, P. L., Meka, A. K., Cavallaro, A. S., Lu, Y., Mitter, N., & Yu, C. (2017) · Nano Research · doi:10.1007/s12274-017-1640-1 · Cited by 18

Establishment of a novel safety assessment method for vaccine adjuvant development

Sasaki, E., Momose, H., Hiradate, Y., Mizukami, T., & Hamaguchi, I. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.10.009 · Cited by 18

GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A Streptococcus

Palmieri, E., Kis, Z., Ozanne, J., Benedetto, R. D., Ricchetti, B., Massai, L., Carducci, M., Oldrini, D., Gasperini, G., Aruta, M. G., et al. (2022) · Vaccines · doi:10.3390/vaccines10071034 · Cited by 18

A review of immune modulators and immunotherapy in infectious diseases

Vijayan, P. S., Xavier, J., & Valappil, M. P. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04825-w · Cited by 19

Reorienting our view of particle-based adjuvants for subunit vaccines

Little, S. R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120993109 · Cited by 18

T h2‐ M 2 immunity in lesions of muscular sarcoidosis and macrophagic myofasciitis

Preuße, C., Goebel, H., Pehl, D., Rinnenthal, J. L., Kley, R. A., Allenbach, Y., Heppner, F. L., Vorgerd, M., Authier, F., Gherardi, R. K., et al. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12231 · Cited by 18

Antibodies elicited by yeast glycoproteins recognize HIV-1 virions and potently neutralize virions with high mannose N-glycans

Zhang, H., Fu, H., Luallen, R. J., Liu, B.-F., Lee, F.-H., Doms, R. W., & Geng, Y. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.08.012 · Cited by 18

Enhanced Protective Immunogenicity of Homodimeric Borrelia burgdorferi Outer Surface Protein C

Edmondson, D. G., Prabhakaran, S., Norris, S. J., Ullmann, A. J., Piesman, J., Dolan, M. C., Probst, C., Radzimski, C., STÖCKER, W., & Komorowski, L. (2016) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00306-16 · Cited by 18

Synthesis of conjugated PIA–rSesC and immunological evaluation against biofilm-forming Staphylococcus epidermidis

Mirzaei, B., Mousavi, S. F., Babaei, R., Bahonar, S., Siadat, S. D., Ardestani, M. S., Shahrooei, M., & Eldere, J. V. (2019) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000910 · Cited by 18

Vaccines for Herpes Simplex: Recent Progress Driven by Viral and Adjuvant Immunology

Sandgren, K. J., Truong, N. R., Smith, J. B., Bertram, K. M., & Cunningham, A. L. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9814-2_2 · Cited by 18

Endocine™, N3OA and N3OASq; Three Mucosal Adjuvants That Enhance the Immune Response to Nasal Influenza Vaccination

Falkeborn, T., Bråve, A., Larsson, M., Åkerlind, B., Schröder, U., & Hinkula, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070527 · Cited by 18

Recent Developments in Immune Activation by Uric Acid Crystals

Ng, G., Chau, E. M. T., & Shi, Y. (2010) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-010-0082-1 · Cited by 18

Enhancement of long-lasting immunoprotective effect against Androctonus australis hector envenomation using safe antigens: Comparative role of MF59 and Alum adjuvants

Nouri, A., & Laraba‐Djebari, F. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.09.045 · Cited by 18

Lactoferrin acts as an adjuvant during influenza vaccination of neonatal mice

Sherman, M. P., Pritzl, C. J., Xia, C., Miller, M. M., Zaghouani, H., & Hahm, B. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.10.067 · Cited by 18

Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria

Milicic, A., Rollier, C. S., Tang, C. K., Longley, R. J., Hill, A. V. S., & Reyes‐Sandoval, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-07246-0 · Cited by 18

Contamination of DNase Preparations Confounds Analysis of the Role of DNA in Alum-Adjuvanted Vaccines

Doepker, L. E., White, J., Cambier, J. C., Kappler, J. W., & Marrack, P. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501565 · Cited by 17

Adjuvant-Protein Conjugate Vaccine with Built-In TLR7 Agonist on S1 Induces Potent Immunity against SARS-CoV-2 and Variants of Concern

Zhang, R., Zhou, S., He, C.-B., Wang, J., Wen, Y., Feng, R.-R., Yin, X., Yang, G., & Guo, J. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00259 · Cited by 17

Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections

Koger-Pease, C., Perera, D. J., & Ndao, M. (2023) · Pharmaceuticals · doi:10.3390/ph16030334 · Cited by 18

Adjuvant-dependent impact of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus

Dillard, J. A., Taft-Benz, S., Knight, A. C., Anderson, E. J., Pressey, K. D., Parotti, B., Martinez, S. A., Diaz, J., Sarkar, S., Madden, E. A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47450-x · Cited by 16

Reduced immune reaction prevents immunopathology after challenge with avian influenza virus: A transcriptomics analysis of adjuvanted vaccines

Reemers, S. S. N., Jansen, C. A., Koerkamp, M. J. A. G., van Haarlem, D. A., van de Haar, P. M., Degen, W. G. J., van Eden, W., & Vervelde, L. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.06.099 · Cited by 17

The Use of Xanthan Gum as Vaccine Adjuvant: An Evaluation of Immunostimulatory Potential in BALB/c Mice and Cytotoxicity In Vitro

Schuch, R. A., Oliveira, T. L., Collares, T. F., Monte, L. G., Inda, G. R., Dellagostin, O. A., Vendruscolo, C. T., Moreira, A. D. S., & Hartwig, D. D. (2017) · BioMed Research International · doi:10.1155/2017/3925024 · Cited by 17

Impact of eosinophil-peroxidase (EPX) deficiency on eosinophil structure and function in mouse airways

Percopo, C. M., Krumholz, J. O., Fischer, E. R., Kraemer, L. S., Ma, M., Laky, K., & Rosenberg, H. F. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ab0318-090rr · Cited by 19

Evolution of adjuvants across the centuries

Garçon, N., Hem, S. L., & Friede, M. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00020-3 · Cited by 18

Hemagglutinin Nanoparticulate Vaccine with Controlled Photochemical Immunomodulation for Pathogenic Influenza‐Specific Immunity

Jeong, H., Lee, C., Lee, J., Lee, J., Hwang, H. S., Lee, M., & Na, K. (2021) · Advanced Science · doi:10.1002/advs.202100118 · Cited by 17

Flower-like mesoporous silica nanoparticles as an antigen delivery platform to promote systemic immune response

Hou, F., Teng, Z., Ru, J., Liu, H., Li, J., Zhang, Y., Sun, S., & Guo, H. (2022) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2022.102541 · Cited by 17

Advanced materials for the delivery of vaccines for infectious diseases

Li, W., Meng, J., Ma, X., Lin, J., & Lu, X. (2022) · Biosafety and Health · doi:10.1016/j.bsheal.2022.03.002 · Cited by 17

Manipulation of EAT-2 expression promotes induction of multiple beneficial regulatory and effector functions of the human innate immune system as a novel immunomodulatory strategy

Aldhamen, Y. A., Seregin, S. S., Aylsworth, C. F., Godbehere, S., & Amalfitano, A. (2013) · International Immunology · doi:10.1093/intimm/dxt061 · Cited by 17

Allergic patients with and without allergen-specific immunotherapy mount protective immune responses to tick-borne encephalitis vaccination in absence of enhanced side effects or propagation of their Th2 bias

Garner‐Spitzer, E., Seidl-Friedrich, C., Zwazl, I., Hofer, M., Kinaciyan, T., Jarisch, R., Stiasny, K., Zlabinger, G. J., Kundi, M., & Wiedermann, U. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.03.076 · Cited by 17

A Novel SARS-CoV-2 Multitope Protein/Peptide Vaccine Candidate is Highly Immunogenic and Prevents Lung Infection in an AAV hACE2 Mouse Model and non-human primatesPreprint

Guirakhoo, F., Kuo, L., Peng, J., Huang, J.-H., Kuo, B.-S., Lin, F., Liu, Y.-J., Liu, Z., Wu, G., Ding, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.30.399154 · Cited by 16

Aluminium adjuvants used in vaccines versus placebo or no intervention

Djurisic, S., Jakobsen, J. C., Petersen, S. B., Kenfelt, M., & Gluud, C. N. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012805 · Cited by 20

Cricket paralysis virus internal ribosome entry site-derived RNA promotes conventional vaccine efficacy by enhancing a balanced Th1/Th2 response

Kwak, H. W., Park, H., Ko, H. L., Park, H.-L., Ho, M., Lee, S., Kang, K. W., Kim, R., Ryu, S. R., Kim, H. J., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.07.070 · Cited by 16

Vaccine for Diabetes—Where Do We Stand?

Chellappan, D. K., Bhandare, R. R., SHAIK, A. B., Prasad, K., Suhaimi, N. A. A., Yap, W. S., Das, A., Banerjee, P., Ghosh, N., Guith, T., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169470 · Cited by 16

A potent, broadly protective vaccine against SARS-CoV-2 variants of concern

Wang, Z., An, J., Liu, K., Yü, P., Fang, X. D., Li, J., Zhu, H., Zhu, Q., Huang, C., Zhang, C., et al. (2022) · npj Vaccines · doi:10.1038/s41541-022-00571-0 · Cited by 15

Peptide Vaccines in Melanoma: Chemical Approaches towards Improved Immunotherapeutic Efficacy

Biri‐Kovács, B., Bánóczi, Z., Tummalapally, A., & Szabó, I. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020452 · Cited by 16

Facile Preparation of Carbohydrate‐Containing Adjuvants Based on Self‐Assembling Glycopeptide Conjugates

Wang, B., Liu, S., Li, H., Dong, W., Liu, H., Zhang, J., Tian, C., & Dong, S. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202309140 · Cited by 16

Manganese‐Modified Aluminum Adjuvant Enhances both Humoral and Cellular Immune Responses

Li, Y., Wang, C., Lv, H., Li, J., Zhang, X., Zhang, S., Shen, Q., Wu, Q., Liu, Y., Peng, R., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401675 · Cited by 16

Safety and efficacy of toll-like receptor agonists as therapeutic agents and vaccine adjuvants for infectious diseases in animals: a systematic review

Oboge, H., Riitho, V., Mutono, N., Omondi, G. P., Lacasta, A., Githaka, N., Nene, V. M., Aboge, G. O., & Thumbi, S. M. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1428713 · Cited by 16

Adjuvants in micro‐ to nanoscale: current state and future direction

Gupta, A., Das, S., Schanen, B. C., & Seal, S. (2015) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1354 · Cited by 16

Influenza Nucleoprotein Delivered with Aluminium Salts Protects Mice from an Influenza A Virus That Expresses an Altered Nucleoprotein Sequence

MacLeod, M. K. L., David, A. P., Jin, N., Noges, L., Wang, J., Kappler, J. W., & Marrack, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061775 · Cited by 16

Cumulative inactivated vaccine exposure and allergy development among children: a birth cohort from Japan

Yamamoto‐Hanada, K., Pak, K., Saito‐Abe, M., Yang, L., Sato, M., Mezawa, H., Sasaki, H., Nishizato, M., Konishi, M., Ishitsuka, K., et al. (2020) · Environmental Health and Preventive Medicine · doi:10.1186/s12199-020-00864-7 · Cited by 16

Beyond the amyloid hypothesis: how current research implicates autoimmunity in Alzheimer’s disease pathogenesis

Chatanaka, M. K., Sohaei, D., Diamandis, E. P., & Prassas, I. (2023) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2023.2187342 · Cited by 15

I g E knock‐in mice suggest a role for high levels of I g E in basophil‐mediated active systemic anaphylaxis

Lübben, W., Turqueti‐Neves, A., Okhrimenko, A., Stöberl, C., Schmidt, V., Pfeffer, K., Dehnert, S., Wünsche, S., Storsberg, S., Paul, S., et al. (2013) · European Journal of Immunology · doi:10.1002/eji.201242675 · Cited by 16

Evaluating the efficacy of rBmHATαc as a multivalent vaccine against lymphatic filariasis in experimental animals and optimizing the adjuvant formulation

Dakshinamoorthy, G., & Kalyanasundaram, R. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.10.083 · Cited by 16

Lipid nanocapsule as vaccine carriers for his-tagged proteins: Evaluation of antigen-specific immune responses to HIV I His-Gag p41 and systemic inflammatory responses

Wadhwa, S., Jain, A., Woodward, J. G., & Mumper, R. J. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.10.016 · Cited by 16

Doubly Phosphorylated Peptide Vaccines to Protect Transgenic P301S Mice against Alzheimer’s Disease Like Tau Aggregation

Richter, M., Mewes, A., Fritsch, M., Krügel, U., Hoffmann, R., & Singer, D. L. (2014) · Vaccines · doi:10.3390/vaccines2030601 · Cited by 17

Sequestering of damage-associated molecular patterns (DAMPs): a possible mechanism affecting the immune-stimulating properties of aluminium adjuvants

Svensson, A., Sandberg, T., Siesjö, P., & Eriksson, H. (2017) · Immunologic Research · doi:10.1007/s12026-017-8972-5 · Cited by 16

Neisserial PorB immune enhancing activity and use as a vaccine adjuvant

Yuen, R. R., Kuniholm, J., Lisk, C., & Wetzler, L. M. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1609852 · Cited by 16

Enhanced Antitumor Immunity of a Globo H‐Based Vaccine Enabled by the Combination Adjuvants of 3D‐MPL and QS‐21

Ma, W., Xu, Z., Teng, C., Cao, C., Wu, R., Xiao, M., Sui, Q., Gao, Q., Zong, C., & Li, T. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202418948 · Cited by 15

Rational design of innate defense regulator peptides as tumor vaccine adjuvants

Tian, Y., Hu, Q., Zhang, R., Zhou, B., Xie, D., Wang, Y., Zhang, X., & Yang, L. (2021) · npj Vaccines · doi:10.1038/s41541-021-00334-3 · Cited by 15

Self-Adjuvanting TLR7/8 Agonist and Fentanyl Hapten Co-Conjugate Achieves Enhanced Protection against Fentanyl Challenge

Powers, N., Massena, C., Crouse, B., Smith, M., Hicks, L., Evans, J. T., Miller, S., Pravetoni, M., & Burkhart, D. (2023) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.3c00347 · Cited by 15

Montmorillonite nanosheets as an adjuvant eliciting potent cellular immunity

Yang, Z., Li, L., Zhong, L., Wen, Z., Chen, H., Xu, M., Liu, H., Liu, L., & Chen, Y. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.148612 · Cited by 15

Th2 and Th17‐associated immunopathology following SARS‐CoV‐2 breakthrough infection in Spike‐vaccinated ACE2‐humanized mice

Zhang, T., Magazine, N., McGee, M. C., Carossino, M., Veggiani, G., Kousoulas, K. G., August, A., & Huang, W. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29408 · Cited by 16

A rational designed multi-epitope vaccine elicited robust protective efficacy against Klebsiella pneumoniae lung infection

Liao, J., Zhang, X., Zeng, X., Zhao, Z., Sun, T., Xia, Z., Jing, H., Yuan, Y., Chen, Z., Gou, Q., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116611 · Cited by 15

TLR9 and endogenous adjuvants of the whole blood-stage malaria vaccine

Coban, C., Horii, T., Akira, S., & Ishii, K. J. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.60 · Cited by 15

Immune responses of a meningococcal A + W outer membrane vesicle (OMV) vaccine with and without aluminium hydroxide adjuvant in two different mouse strains

Tunheim, G., Arnemo, M., Næss, L. M., Norheim, G., García, L. G., Cardoso, D., Mandiarote, A., González, D., Sinnadurai, K., Fjeldheim, Å. K., et al. (2016) · Apmis · doi:10.1111/apm.12589 · Cited by 15

Nonthermal plasma as part of a novel strategy for vaccination

Mohamed, H., Esposito, R. A., Kutzler, M. A., Wigdahl, B. L., Krebs, F. C., & Miller, V. (2020) · Plasma Processes and Polymers · doi:10.1002/ppap.202000051 · Cited by 15

Improved Aluminum Adjuvants Eliciting Stronger Immune Response When Mixed with Hepatitis B Virus Surface Antigens

Wang, Z., Li, S., Shan, P., Wei, D., Hao, S., Zhang, Z., & Xu, J. (2022) · ACS Omega · doi:10.1021/acsomega.2c04266 · Cited by 15

Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics

Sayour, E. J., Sanchez-Perez, L. A., Flores, C., & Mitchell, D. A. (2015) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-015-0058-0 · Cited by 15

Chitin enhances serum IgE in Aspergillus fumigatus induced allergy in mice

Dubey, L. K., Moeller, J. B., Schlosser, A. G., Sørensen, G. L., & Holmskov, U. (2015) · Immunobiology · doi:10.1016/j.imbio.2015.01.002 · Cited by 15

Immunogenicity of Antigen Adjuvanted with AS04 and Its Deposition in the Upper Respiratory Tract after Intranasal Administration

Xu, H., Alzhrani, R. F., Warnken, Z. N., Thakkar, S. G., Zeng, M., Smyth, H. D. C., Williams, R. O., & Cui, Z. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00372 · Cited by 15

Glycoconjugate Vaccines for Prevention of Haemophilus influenzae Type b Diseases

Khatuntseva, E. A., & Nifantiev, N. E. (2021) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162021010106 · Cited by 15

Hypothesis driven development of new adjuvants

Dong, J. C., & Kobinger, G. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.22972 · Cited by 15

Deep learning in next-generation vaccine development for infectious diseases

Bhattacharya, M., Lo, Y.-H., Chatterjee, S., Das, A., Wen, Z., & Chakraborty, C. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102586 · Cited by 19

Assessment of the immunogenicity and protection of a Nipah virus soluble G vaccine candidate in mice and pigs

Gao, Z., Li, T., Han, J., Feng, S., Li, L., Jiang, Y., Xu, Z., Hao, P., Chen, J., Hao, J., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1031523 · Cited by 14

STING and TLR9 agonists synergistically enhance the immunogenicity of SARS-CoV-2 subunit vaccine

Li, Y., Chen, Z., Lu, X., Sun, J., Guo, M., Zhou, H., Bai, R., Zhao, Y., Chen, C., & Wang, Y. (2023) · Nano Research · doi:10.1007/s12274-023-6295-5 · Cited by 14

Opportunities and Challenges for Nanomaterials as Vaccine Adjuvants

Li, Z., Chen, P., Qu, A., Sun, M., Xu, L., Xu, C., Hu, S., & Kuang, H. (2025) · Small Methods · doi:10.1002/smtd.202402059 · Cited by 14

Biodistribution of vaccines comprised of hydrophobically-modified poly(γ-glutamic acid) nanoparticles and antigen proteins using fluorescence imaging

Toita, R., Nakao, K., Mahara, A., Yamaoka, T., & Akashi, M. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.08.024 · Cited by 14

Vitamins as influenza vaccine adjuvant components

Quintilio, W., de Freitas, F. A., Rodriguez, D., Kubrusly, F. S., Yourtov, D., Miyaki, C., Leite, L. C. C., & Raw, I. (2016) · Archives of Virology · doi:10.1007/s00705-016-2994-5 · Cited by 14

Characterization of the innate stimulatory capacity of plant-derived virus-like particles bearing influenza hemagglutinin

Won, S., Hunt, K., Guak, H., Hasaj, B., Charland, N., Landry, N., Ward, B. J., & Krawczyk, C. M. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.10.099 · Cited by 14

Prefusion F–Based Polyanhydride Nanovaccine Induces Both Humoral and Cell-Mediated Immunity Resulting in Long-Lasting Protection against Respiratory Syncytial Virus

Stephens, L. M., Ross, K. A., Waldstein, K. A., Legge, K. L., McLellan, J. S., Narasimhan, B., & Varga, S. M. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100018 · Cited by 15

Vaccination of mice with hybrid protein containing Exotoxin S and PcrV with adjuvants alum and MPL protects Pseudomonas aeruginosa infections

Karam, M. R. A., Badmasti, F., Ahmadi, K., & Habibi, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-05157-3 · Cited by 16

Clearance, biodistribution, and neuromodulatory effects of aluminum-based adjuvants. Systematic review and meta-analysis: what do we learn from animal studies?

Masson, J.-D., Angrand, L., Badran, G., de Miguel, R., & Crépeaux, G. (2022) · Critical Reviews in Toxicology · doi:10.1080/10408444.2022.2105688 · Cited by 16

Phenotype and function of protective, CD4-independent CD8 T cell memory

Edwards, L. E., Haluszczak, C., & Kedl, R. M. (2012) · Immunologic Research · doi:10.1007/s12026-012-8356-9 · Cited by 14

Polymers in the Delivery of siRNA for the Treatment of Virus Infections

Reynolds, N. P., Dearnley, M., & Hinton, T. M. (2017) · Topics in Current Chemistry · doi:10.1007/s41061-017-0127-6 · Cited by 15

An inactivated hand-foot-and-mouth disease vaccine using the enterovirus 71 (C4a) strain isolated from a Korean patient induces a strong immunogenic response in mice

In, H. J., Lim, H., Lee, J.-A., Kim, H. J., Kim, J.-W., Hyeon, J.-Y., Yeo, S.-G., Lee, J.-W., Yoo, J. S., Choi, Y. K., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178259 · Cited by 14

Active Immunization

Strikas, R. A., Mawle, A. C., Pickering, L. K., & Orenstein, W. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00006-2 · Cited by 14

Safety and Utility of Rush Immunotherapy with Aqueous Allergen Extracts for Treatment of Respiratory Allergies

Lee, J.-H., Choi, J.-H., Jeong, K.-B., Lee, S. J., Lee, M. K., Lee, W., Yong, S. J., & Kim, S. (2021) · Journal of Korean Medical Science · doi:10.3346/jkms.2021.36.e18 · Cited by 14

A Highly Immunogenic Measles Virus-based Th1-biased COVID-19 VaccinePreprint

Hörner, C., Schürmann, C., Auste, A., Ebenig, A., Muraleedharan, S., Herrmann, M., Schnierle, B. S., & Mühlebach, M. D. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.11.198291 · Cited by 14

Brief exposure of skin to near‐infrared laser augments early vaccine responses

Yokomizo, S., Katagiri, W., Maki, Y., Sano, T., Inoue, K., Fukushi, M., Atochin, D. N., Kushibiki, T., Kawana, A., Kimizuka, Y., et al. (2021) · Nanophotonics · doi:10.1515/nanoph-2021-0133 · Cited by 14

Dual and multi-immune activation strategies for emerging cancer immunotherapy

Zhang, Y., Liu, L., He, H., Sun, Y., & Zhong, Z. (2024) · Materials Today · doi:10.1016/j.mattod.2024.08.006 · Cited by 13

Nucleic acid vaccines: innovations, efficacy, and applications in at-risk populations

Konopka, E., Edgerton, A. O., & Kutzler, M. A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1584876 · Cited by 14

Properties and prospects of adjuvants in influenza vaccination - messy precipitates or blessed opportunities?

Jalilian, B., Christiansen, S. H., Einarsson, H. B., Pirozyan, M. R., Petersen, E., & Vorup‐Jensen, T. (2013) · Molecular and Cellular Therapies · doi:10.1186/2052-8426-1-2 · Cited by 13

Aluminum Adjuvants in Vaccines: Movement Towards Understanding Their Role and Mechanism of Action

Rehmert, T. (2019) · Blue Tiger Commons (Lincoln University - Missouri)

Application of aluminum in vaccines

Milchev, S., & Valkova, P. (2025) · Natural Science and Advanced Technology Education · doi:10.53656/nat2025-3.23

Tracing aluminium adjuvants in viable cells

Svensson, A., & Eriksson, H. (2016) · Malmö University Publications (Malmö University)

(How) do aluminium adjuvants work?

Brewer, J. M. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.08.002 · Cited by 237

Mechanism of Adjuvanticity of Aluminum-Containing Formulas

Kool, M., & Lambrecht, B. N. (2013) · Springer eBooks · doi:10.1007/978-3-319-00978-0_14 · Cited by 2